Albert Cha, Director at Carbylan Therapeutics, Inc. (CBYL), bought 3,488,952 shares at $5.00 ($5.1M) on 2015-04-14, disclosed to the SEC on 2015-04-27.
Open-market purchase of $5.1M CBYL by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,476,452 | $0 | 0.0% |
| 2 | $5.00 | 7,364 | $37K | 0.7% |
| 3 | $5.00 | 1,005,136 | $5.0M | 99.3% |
| Total | $1.45 avg | 3,488,952 | $5.1M | 100% |
| Filing → |
| KALV | BUY | 2019-07-30 | $1.9M | — | Filing → |
| KALV | BUY | 2019-07-19 | $2.2M | — | Filing → |
| KALV | BUY | 2018-09-12 | $18.0M | — | Filing → |